Cefazolin therapy of urinary tract infections.
D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D004361:Drug Tolerance; D004926:Escherichia coli / Q000302:isolation & purification; D005500:Follow-Up Studies; D006801:Humans; D007273:Injections, Intramuscular; D007711:Klebsiella pneumoniae / Q000302:isolation & purification; D011513:Proteus mirabilis / Q000302:isolation & purification; D013210:Staphylococcus / Q000302:isolation & purification; D013440:Sulfides / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use; D013830:Thiadiazoles / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D002511:Cephalosporins; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles